tPA of human keratinocytes: contribution to cell surface-associated plasminogen activation and upregulation by retinoic acid

Exp Dermatol. 1995 Dec;4(6):357-64. doi: 10.1111/j.1600-0625.1995.tb00060.x.

Abstract

We tested distinct variants of a human keratinocyte line (HaCaT) for the expression of tissue-type plasminogen activator (tPA)-specific mRNA, as well as cell surface-associated and secreted tPA. Cells of early passages (passage no. 22) only expressed urokinase plasminogen activator (uPA)- but not tPA-specific mRNA. Cells after prolonged culture (passage no. 44) expressed uPA- and tPA-specific mRNA, but did not release tPA in the extracellular space and did not display surface-associated tPA. HaCaT cells transformed with the c-Ha-ras oncogene (HaCaTras) showed both secreted and surface-associated tPA antigen. The secreted and the surface-associated plasminogen activator (PA)-activity of HaCaTras cells were in part inhibitable by anticatalytic anti-tPA antibodies, thus indicating that tPA contributes to extracellular and surface-associated plasminogen activation. Finally, we demonstrate that tPA secretion of HaCaT 44 cells can be induced by retinoic acid, most likely via interaction of retinoic acid with nuclear-associated retinoic acid-receptor(s).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Cell Line
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Keratinocytes / cytology
  • Keratinocytes / drug effects
  • Keratinocytes / metabolism*
  • Keratolytic Agents / pharmacology*
  • Molecular Sequence Data
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Tissue Plasminogen Activator / drug effects
  • Tissue Plasminogen Activator / genetics
  • Tissue Plasminogen Activator / metabolism*
  • Tretinoin / pharmacology*
  • Up-Regulation
  • Urokinase-Type Plasminogen Activator / metabolism

Substances

  • Keratolytic Agents
  • RNA, Messenger
  • Tretinoin
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator